IMPAIRED INTERFERON-ALPHA ENHANCEMENT OF NEONATAL MONOCYTE PHAGOCYTOSIS

被引:0
|
作者
ELMOHANDES, AE
BRUDNO, DS
AHRONOVICH, MD
机构
[1] GEORGE WASHINGTON UNIV,SCH MED,DEPT PEDIAT,WASHINGTON,DC 20052
[2] MED COLL GEORGIA,DEPT PEDIAT,AUGUSTA,GA 30912
[3] CHILDRENS HOSP,NATL MED CTR,DIV NEONATOL,WASHINGTON,DC 20010
来源
BIOLOGY OF THE NEONATE | 1990年 / 58卷 / 05期
关键词
INTERFERON-ALPHA; MONONUCLEAR PHAGOCYTOSIS; CORD BLOOD MONOCYTES;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Monocyte phagocytic activity was tested in 10 healthy term newborns using a later phagocytic assay. The baseline phagocytic activity in the cord blood monocytes (37.7 +/- 3.8%) was comparable to adult controls (38.5 +/- 9.4%). When enhanced with 1,000 U/ml of alpha-interferon, the phagocytic activity was lower in cord blood monocytes (40.5 +/- 3.4%) than in the adult controls (47.9 +/- 10.6%), but this difference reached statistical significance only when the cord blood monocytes were enhanced with 2,000 U/ml reaching 43.6 +/- 4.3% in cord blood monocytes, as compared to 54.6 +/- 9.6% in adult controls. These findings may explain an inherent functional deficiency in the neonatal mononuclear phagocytic system which may not be evident during the quiescent phase of monocyte/macrophage activity, but may become apparent during an infectious challenge.
引用
收藏
页码:260 / 263
页数:4
相关论文
共 50 条
  • [1] ENHANCEMENT OF MONOCYTE-MEDIATED TUMORICIDAL ACTIVITY BY MULTIPLE INTERFERON-ALPHA SPECIES
    WEBB, DSA
    NEDDEN, DZ
    MILLER, DM
    ZOON, KC
    GERRARD, TL
    CELLULAR IMMUNOLOGY, 1989, 124 (01) : 158 - 167
  • [2] ENHANCEMENT OF HUMAN MONOCYTE CYTO-TOXICITY BY MULTIPLE SPECIES OF INTERFERON-ALPHA
    WEBB, D
    ZOON, K
    ZURNEDDEN, D
    GERRARD, T
    JOURNAL OF LEUKOCYTE BIOLOGY, 1988, 44 (04) : 280 - 280
  • [3] Impaired interferon-alpha production by plasmacytoid dendritic cells
    Ulsenheimer, A
    Jung, MC
    Gerlach, JT
    Gruener, N
    Schirren, CA
    Waechtler, M
    Backmund, M
    Schraut, W
    Zachoval, R
    Pape, GR
    Diepolder, HM
    JOURNAL OF HEPATOLOGY, 2004, 40 : 124 - 124
  • [4] Impaired thermal and tactile sensitivity during interferon-alpha treatment
    Malaguarnera, M
    Pistone, G
    Trovato, BA
    Panebianco, P
    Rampello, L
    CLINICAL DRUG INVESTIGATION, 1996, 12 (05) : 271 - 273
  • [5] INDUCTION OF INTERFERON-ALPHA BY INTERFERON-BETA, BUT NOT OF INTERFERON-BETA BY INTERFERON-ALPHA, IN THE MOUSE
    ASANO, M
    HAYASHI, M
    YOSHIDA, E
    KAWADE, Y
    IWAKURA, Y
    VIROLOGY, 1990, 176 (01) : 30 - 38
  • [6] INTERFERON-ALPHA IN LYMPHOMA
    ROHATINER, AZS
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 : 26 - 29
  • [7] NEUROTOXICITY OF INTERFERON-ALPHA
    MERIMSKY, O
    CHAITCHIK, S
    ANTI-CANCER DRUGS, 1992, 3 (06) : 567 - 570
  • [8] INTERFERON-ALPHA HYBRIDS
    HORISBERGER, MA
    DIMARCO, S
    PHARMACOLOGY & THERAPEUTICS, 1995, 66 (03) : 507 - 534
  • [9] IS INTERFERON-ALPHA ATHEROGENIC
    KUDER, P
    ABERGEL, A
    JOUANEL, P
    BONNY, C
    BRUN, H
    HENQUELL, C
    LAFEUILLE, H
    BOMMELAER, G
    HEPATOLOGY, 1995, 22 (04) : 1342 - 1342
  • [10] INTERFERON-ALPHA AND AUTOIMMUNITY
    PAPO, T
    PIETTE, JC
    DU, LTH
    GODEAU, P
    ANNALES DE MEDECINE INTERNE, 1993, 144 (05): : 357 - 366